G蛋白结合雌激素受体 (GPER):癌症治疗的关键治疗标
Keith A Hall1, Edward J Filardo1
1Starling Biosciences, Inc., Coralville, IA 52241, USA.
Cells
|October 27, 2023
概括
雌激素受体 (ERα,ERβ和GPER) 驱动癌症的生长. 目前针对ERα和ERβ的治疗方法不足,突出显示需要G蛋白结合雌激素受体 (GPER) 向治疗以获得更好的结果.
科学领域:
- 在瘤学瘤学.
- 内分泌学 在内分泌学.
- 分子生物学分子生物学
背景情况:
- 雌激素在各种癌症中起着关键作用,人们越来越担心环境中的雌激素.
- 雌激素信号传递通过雌激素受体 (ERα,ERβ和GPER) 发生,通过反应元素影响基因转录.
- 目前的抗雌激素疗法主要集中在ERα和ERβ上,忽视了GPER的作用.
研究的目的:
- 审查G蛋白结合雌激素受体 (GPER) 在由雌激素驱动的恶性瘤中的重要性.
- 强调目前不针对GPER的治疗方法的局限性.
- 在全面的癌症治疗策略中倡导GPER向治疗方法.
主要方法:
- 文献综述侧重于雌激素受体和癌症病原性.
- 分析当前内分泌疗法及其作用机制.
- 评估GPER在瘤进展和内分泌抵抗中的作用.
主要成果:
- 雌激素受体 (ERα,ERβ,GPER) 在癌症中介导雌激素效应.
- 针对ERα/ERβ的现有疗法没有针对GPER,GPER是一种与瘤生长和转移相关的受体.
- GPER与瘤大小,转移,癌症干细胞活性和内分泌抵抗有关.
结论:
- 在由雌激素驱动的癌症中,GPER是关键目标.
- 针对GPER对于更完整的治疗反应至关重要.
- 针对GPER的治疗方法是整体癌症治疗策略的重要组成部分.
相关概念视频
G Protein-coupled Receptors
12.2K
G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
12.2K
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Transducer Mechanism: G Protein–Coupled Receptors
2.0K
G Protein–Coupled Receptors (GPCRs) are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to various stimuli. GPCRs regulate critical physiological pathways and are excellent drug targets for treating diseases such as diabetes, cancer, obesity, depression, or Alzheimer's. Nearly 35% of approved drugs implement their therapeutic effects by selectively interacting with specific GPCRs.
GPCRs are also called heptahelical,...
GPCRs are also called heptahelical,...
2.0K
Transducer Mechanism: Enzyme-Linked Receptors
2.5K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.5K
GPCRs Regulate Adenylyl Cylase Activity
5.6K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
5.6K


